News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Axxess Pharma, Inc. To Launch High Protein, Fat Burning Ready To Drink (RTD) Protein Meal Replacement Products In Fall Of 2014


6/24/2014 10:26:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TORONTO, ON--(Marketwired - June 24, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., that they will be launching a line high protein, fat burning Ready to Drink (RTD), protein meal replacement products in the fall of 2014. The early launch of these products was fueled by the strong feedback from several large, national US retailers.

Axxess has been working with its Australian distributor, and formulator, and has developed a suite of high demand, high-quality products. For years, the Australian and New Zealand dairy herds have been the optimal source for their whey protein and providing the finest protein supplements. These meal replacement/protein drinks have several advantages over the competition. Axxess Pharma believes this will translate into strong residual sales.

Dr. Bagi, President of Axxess Pharma stated: "The timing is perfect for these new products, especially with the high level of interest shown from our ECRM buyers' meetings of last week. Thanks to the R & D efforts in Australia, we have developed a great tasting product with the added benefit of being able to integrate L-Carnitine into the formula, giving the products a unique combination of high protein intake, with the added benefit of fat-burning even when not working out."

Dr. Bagi, further stated, "This line of meal replacement protein-building products can satisfy both the high-performance athlete as well as persons just wishing to replace a meal with a product that will help them burn fat."

About Axxess Pharma Inc.: Axxess Pharma Inc. is a Nevada Corporation operating through its wholly owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements. To learn more about our new products TapouT Extreme Muscle Growth and TapouT Muscle Recovery, please visit: http://buytapoutme.com and http://www.tapoutmusclerecovery.com.

For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.

About TapouT: TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit TapouT.com.
https://www.facebook.com/TapouT
https://twitter.com/TapouT
http://www.youtube.com/tapout

Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks, estimated, expected, intended or projected. In each instance, forward-looking information should be and uncertainties.


Contact:

Investor Relations
Taylor Capitol, Inc.
Stephen Taylor
(973) 351-3868
staylor@TheStockAlerts.com
www.TheStockAlerts.com

Media Relations:
Jamie Schnee- PR
Nutritional Products International
(561) 544-0719
jamies@inhealthmedia.com



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES